Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Teva
Cantor Fitzgerald
Covington
Johnson and Johnson
McKesson
Accenture
Colorcon
QuintilesIMS

Generated: April 23, 2018

DrugPatentWatch Database Preview

CAMBIA Drug Profile

« Back to Dashboard

Which patents cover Cambia, and when can generic versions of Cambia launch?

Cambia is a drug marketed by Depomed Inc and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-eight patent family members in twenty-one countries.

The generic ingredient in CAMBIA is diclofenac potassium. There are forty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.
Drug patent expirations by year for CAMBIA
Synonyms for CAMBIA
15307-81-0
15307-86-5 (Parent)
2-((2,6-dichlorophenyl)amino)benzeneacetic acid, monopotassium salt
AB0013318
AC-18735
AK163133
AKOS015889752
AKOS015994733
AN-8291
Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monopotassium salt
C14H10Cl2KNO2
C14H10Cl2NO2.K
Cambia (TN)
Cataflam
Cataflam (TN)
CGP 45840B
CGP-45840B
CHEBI:4508
CHEMBL1200804
D00903
Diclofenac potassium
Diclofenac potassium (USAN)
Diclofenac potassium [USAN:USP]
Diclofenac potassium [USAN]
Diclofenic potassium
DR001603
DTXSID30165212
FT-0603076
H866
HMS3656D18
I01-3215
KS-5037
KXZOIWWTXOCYKR-UHFFFAOYSA-M
L4D5UA6CB4
LS-173441
MolPort-005-937-655
Potassium (o-(2,6-dichloroanilino)phenyl)acetate
potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate
potassium 2-[2-(2,6-dichloroanilino)phenyl]acetate
potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
PubChem5895
s3062
SC-01315
SCHEMBL40784
ST51051764
UNII-L4D5UA6CB4
Voltfast
Zipsor
Zipsor (TN)

US Patents and Regulatory Information for CAMBIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Depomed Inc CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Depomed Inc CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Depomed Inc CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Depomed Inc CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CAMBIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Depomed Inc CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Depomed Inc CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for CAMBIA
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Potassium Oral Solution (Sachet) 50 mg ➤ Subscribe 2011-01-24

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Chinese Patent Office
Accenture
QuintilesIMS
Merck
Harvard Business School
Moodys
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.